NCT02080741终止不适用
Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 57
- 试验地点
- 1
- 主要终点
- Telomere length
研究概览
简要总结
This study will include 100 patients with Type 1 and Type 2 diabetes, split into 2 groups of 50 patients according to their behaviour type, and their adaptation to different factors of stress encountered in their lives:
- the first group will consist of patients with a characteristic Type A behaviour profile, that is to say patients with a "proactive, impatient" behaviour pattern
- the second group will consist of patients with a characteristic Type B behaviour profile that is to say patients with a "calm, slow" behaviour pattern The objective is to know if the different behaviour patterns are associated with distinct biological markers likely to influence the evolution of the diabetes.
Participation in this study will be approximately 1h30, patients will participate ONCE ONLY:
- they will answer simple questions about their disease and then complete 3 questionnaires each with 14 items.
- they will meet a clinical psychologist for an interview lasting approximately 45 minutes recorded on an audio recorder. The consultation will be used to seek links between the psyche and the disease.
- they will provide one blood sample of 12 ml (equivalent to a soup spoon) drawn in the morning.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who have provided written informed consent
- •Patients with type 1 or type 2 diabetes
- •Patient admitted for a consultation, as out or in-patients to the Endocrinology-Diabetology-Metabolic diseases department of Dijon CHU
- •Patient > 18 years
- •Patient with either a characteristic Type A behaviour profile (Bortner > 210), or a characteristic Type B behaviour profile (Bortner<154)
排除标准
- •Persons not covered by national health insurance
- •Adults under guardianship or wards of court or not intellectually independent
- •Patients without diabetes
- •Patients with a mixed A/B behaviour profile (154< Bortner score <210)
- •Pregnant or breast-feeding women
研究组 & 干预措施
Type A behaviour profile
Other
干预措施: Blood sample of 12 ml (Other)
Type B behaviour profile
Other
干预措施: Blood sample of 12 ml (Other)
结局指标
主要结局
Telomere length
时间窗: Baselines
次要结局
- Level of expression of candidate genes(Baselines)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
SWITCH - Sensing With Insulin Pump Therapy to Control HbA1cDiabetes Mellitus, Type 1NCT00598663Medtronic Diabetes153
已完成
不适用
Glycemic Response to Two Enteral Formulas in Persons With Type 2 Diabetes MellitusDiabetesNCT02898766Société des Produits Nestlé (SPN)12
招募中
1 期
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)Diffuse Intrinsic Pontine GliomaHigh Grade GliomaEmbryonal TumorEpendymal TumorNCT04099797Baylor College of Medicine56
终止
不适用
Comparative Metabolomics in Diabetes Patients From Sri Lanka and SwitzerlandDiabetes Mellitus, Type 2NCT05787457Insel Gruppe AG, University Hospital Bern34
进行中(未招募)
早期 1 期
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE DiabetesDiabetes Mellitus, Type 2NCT05105919Montreal Heart Institute50
